149 related articles for article (PubMed ID: 37278034)
1. Associations between HbA1c Reduction and Change in Depressive Symptoms following Glucose-lowering Treatment in Adults: A Systematic Review of Intervention Studies.
Schmitt A; Beran M; Geraets A; Iversen MM; Nefs G; Nouwen A; Pouwer F; Huber JW; Schram MT
Curr Diabetes Rev; 2024; 20(3):e020623217607. PubMed ID: 37278034
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. Psychological interventions to improve self-management of type 1 and type 2 diabetes: a systematic review.
Winkley K; Upsher R; Stahl D; Pollard D; Kasera A; Brennan A; Heller S; Ismail K
Health Technol Assess; 2020 Jun; 24(28):1-232. PubMed ID: 32568666
[TBL] [Abstract][Full Text] [Related]
4. Insulin and glucose-lowering agents for treating people with diabetes and chronic kidney disease.
Lo C; Toyama T; Wang Y; Lin J; Hirakawa Y; Jun M; Cass A; Hawley CM; Pilmore H; Badve SV; Perkovic V; Zoungas S
Cochrane Database Syst Rev; 2018 Sep; 9(9):CD011798. PubMed ID: 30246878
[TBL] [Abstract][Full Text] [Related]
5. Treatment of periodontal disease for glycaemic control in people with diabetes mellitus.
Simpson TC; Weldon JC; Worthington HV; Needleman I; Wild SH; Moles DR; Stevenson B; Furness S; Iheozor-Ejiofor Z
Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD004714. PubMed ID: 26545069
[TBL] [Abstract][Full Text] [Related]
6. Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
Lo C; Jun M; Badve SV; Pilmore H; White SL; Hawley C; Cass A; Perkovic V; Zoungas S
Cochrane Database Syst Rev; 2017 Feb; 2(2):CD009966. PubMed ID: 28238223
[TBL] [Abstract][Full Text] [Related]
7. Continuous Subcutaneous Insulin Infusion (CSII) Pumps for Type 1 and Type 2 Adult Diabetic Populations: An Evidence-Based Analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2009; 9(20):1-58. PubMed ID: 23074525
[TBL] [Abstract][Full Text] [Related]
8. Fixed-Dose Combination of Dapagliflozin + Sitagliptin + Metformin in Patients with Type 2 Diabetes Poorly Controlled with Metformin: Phase 3, Randomized Comparison with Dual Combinations.
Sahay RK; Giri R; Shembalkar JV; Gupta SK; Mohan B; Kurmi P; Kumar SR; Sawardekar VM; Mishra A; Murthy LS; Arya VV; Sonawane AR; Soni PN; Gofne SK; Karnawat SR; Rajurkar MN; Patel PM; Lakhwani LK; Mehta SC; Joglekar SJ
Adv Ther; 2023 Jul; 40(7):3227-3246. PubMed ID: 37258803
[TBL] [Abstract][Full Text] [Related]
9. Treatment of periodontitis for glycaemic control in people with diabetes mellitus.
Simpson TC; Clarkson JE; Worthington HV; MacDonald L; Weldon JC; Needleman I; Iheozor-Ejiofor Z; Wild SH; Qureshi A; Walker A; Patel VA; Boyers D; Twigg J
Cochrane Database Syst Rev; 2022 Apr; 4(4):CD004714. PubMed ID: 35420698
[TBL] [Abstract][Full Text] [Related]
10. Dipeptidyl-peptidase (DPP)-4 inhibitors and glucagon-like peptide (GLP)-1 analogues for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk for the development of type 2 diabetes mellitus.
Hemmingsen B; Sonne DP; Metzendorf MI; Richter B
Cochrane Database Syst Rev; 2017 May; 5(5):CD012204. PubMed ID: 28489279
[TBL] [Abstract][Full Text] [Related]
11. Telephone interventions for symptom management in adults with cancer.
Ream E; Hughes AE; Cox A; Skarparis K; Richardson A; Pedersen VH; Wiseman T; Forbes A; Bryant A
Cochrane Database Syst Rev; 2020 Jun; 6(6):CD007568. PubMed ID: 32483832
[TBL] [Abstract][Full Text] [Related]
12. The bidirectional longitudinal association between depressive symptoms and HbA
Beran M; Muzambi R; Geraets A; Albertorio-Diaz JR; Adriaanse MC; Iversen MM; Kokoszka A; Nefs G; Nouwen A; Pouwer F; Huber JW; Schmitt A; Schram MT;
Diabet Med; 2022 Feb; 39(2):e14671. PubMed ID: 34407250
[TBL] [Abstract][Full Text] [Related]
13. Effect of routinely assessing and addressing depression and diabetes distress on clinical outcomes among adults with type 2 diabetes: a systematic review.
McMorrow R; Hunter B; Hendrieckx C; Kwasnicka D; Speight J; Cussen L; Ho FCS; Emery J; Manski-Nankervis JA
BMJ Open; 2022 May; 12(5):e054650. PubMed ID: 35613752
[TBL] [Abstract][Full Text] [Related]
14. (Ultra-)long-acting insulin analogues versus NPH insulin (human isophane insulin) for adults with type 2 diabetes mellitus.
Semlitsch T; Engler J; Siebenhofer A; Jeitler K; Berghold A; Horvath K
Cochrane Database Syst Rev; 2020 Nov; 11(11):CD005613. PubMed ID: 33166419
[TBL] [Abstract][Full Text] [Related]
15. Home telemonitoring for type 2 diabetes: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2009; 9(24):1-38. PubMed ID: 23074529
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological interventions for the treatment of depression in chronic obstructive pulmonary disease.
Pollok J; van Agteren JE; Carson-Chahhoud KV
Cochrane Database Syst Rev; 2018 Dec; 12(12):CD012346. PubMed ID: 30566235
[TBL] [Abstract][Full Text] [Related]
17. Management of type 2 diabetes with the dual GIP/GLP-1 receptor agonist tirzepatide: a systematic review and meta-analysis.
Karagiannis T; Avgerinos I; Liakos A; Del Prato S; Matthews DR; Tsapas A; Bekiari E
Diabetologia; 2022 Aug; 65(8):1251-1261. PubMed ID: 35579691
[TBL] [Abstract][Full Text] [Related]
18. Intensive glucose control versus conventional glucose control for type 1 diabetes mellitus.
Fullerton B; Jeitler K; Seitz M; Horvath K; Berghold A; Siebenhofer A
Cochrane Database Syst Rev; 2014 Feb; 2014(2):CD009122. PubMed ID: 24526393
[TBL] [Abstract][Full Text] [Related]
19. Interventions to improve patients' compliance with therapies aimed at lowering glycated hemoglobin (HbA1c) in type 1 diabetes: systematic review and meta-analyses of randomized controlled clinical trials of psychological, telecare, and educational interventions.
Viana LV; Gomes MB; Zajdenverg L; Pavin EJ; Azevedo MJ;
Trials; 2016 Feb; 17():94. PubMed ID: 26888087
[TBL] [Abstract][Full Text] [Related]
20. Glucose targets for preventing diabetic kidney disease and its progression.
Ruospo M; Saglimbene VM; Palmer SC; De Cosmo S; Pacilli A; Lamacchia O; Cignarelli M; Fioretto P; Vecchio M; Craig JC; Strippoli GF
Cochrane Database Syst Rev; 2017 Jun; 6(6):CD010137. PubMed ID: 28594069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
